Tatva Chintan exports its products to more than 25 countries, including USA, China and GermanyTatva Chintan Pharma Chem, a specialty chemical making business, has submitted initial documents with the market regulator Sebi for an initial public offering (IPO).

The IPO will make up a fresh problem of shares worth Rs 225 crore and a deal of sale amounting to Rs 225 crore by existing promoters and shareholders, according to the business's draft red herring prospectus.Tatva Chintan Pharma Chem will use the IPO continues to fund its capital investment requirements, expand the Dahej production center and for basic business purposes.Based in Vadodara, Tatva Chintan exports its products to more than 25 nations, including the U.S.A., China, Germany, Japan, South Africa and the UK.ICICI Securities and JM Financials are the merchant lenders to the concern of Tatva Chintan Pharma.